Studying the microbiome of the lung in patients treated with endobronchial lung volume reduction coils for emphysema, Study contact information Co-Design of a Pulmonary Rehabilitation intervention to Improve outcomes post-Exacerbation in Bronchiectasis, Study contact information Identifying incidence and nature of Fatigue in Individuals infected with COVID-19 (SARS-Cov-2) in the United Kingdom, Study contact information Find out more. Autoantibody Predictors of Long-Term Outcomes in Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease. Singing for Health: Improving Experience of Lung Disease, Study contact information Impact of premature birth on the gastrointestinal microbiota in early infancy and respiratory health at school age: a comparison of premature and term birth cohorts. Name:Dr Anand DevarajEmail:a.devaraj@rbht.nhs.uk, Study Name: Dr Mahmoud BarbirEmail: M.Barbir@rbht.nhs.uk. Name:Darshan BrahmbhattEmail:d.brahmbhatt@rbht.nhs.uk, Study Acute muscle wasting in critical illness an observational cohort study. PRISM: Molecular phenotyping of participants with severe asthma to determine response to biologic therapies and stability, Study Study contact information Studying the airway microenvironment in patients undergoing surgical and bronchoscopic interventions for COPD, Study An open-label extension trial to assess the long term safety of nintedanib in patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD), Study contact information Name:Sandra ScottEmail:S.Scott@rbht.nhs.uk, Study Professor Stephen Durham. Study contact informationName: Dr John WortEmail:S.Wort@rbht.nhs.uk. Study The Effects of Planned Intravenous Antibiotics on Activity and Sleep Quality in Cystic Fibrosis During the Post COVID-19 Lockdown Period, Study contact information Appointment enquiries: 0207 351 8011 (Royal Brompton) 01895 828 696 (Harefield) or your consultant's secretary. Click to view your profile; Click to search for condition or expert; Click to open main menu; Save Bookmark Share Share. Name:Ahmad SadakaEmail:A.Sadaka@rbht.nhs.uk, Study Dr James Darius-Armstrong, Study Study Name: Kartik KumarEmail: K.Kumar2@rbht.nhs.uk, Study Phase III PoCC pivotal trial #1 BI 1015550 - PDE4 inhibitor in AF experienced PF-ILD. Ben Garfield's research works | Royal Brompton and Harefield NHS Study Benjamin E. Garfield | MediFind A study of concomitant epicardial left atrial appendage closure and catheter ablation in treating recurrent persistent atrial fibrillation after failed previous ablation, Study contact information Study PROSAIC-19 Prospective longitudinal assessment in a COVID-19 infected cohort, Study contact information Name: Jennifer KilduffEmail: j.kilduff@rbht.nhs.uk, Study A Randomised controlled trial to Assess the Safety and Efficiency of a self-Contained sampling device /disposable bronchoscope system versus usual sAmpLing procedure. The UK Interstitial Lung Disease Long-COVID19 study (UKILD-Long COVID): understanding the burden of Interstitial Lung Disease in Long COVID, Study contact information Genetics of susceptibility and mortality in critical care (GenOMICC), Study contact information Development of Cardiovascular Magnetic Resonance (CMR) sequences for future clinical use, Study contact information Name:DeepaArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk, Principal investigator Name:Nicole WestruppEmail:n.westrupp@rbht.nhs.uk, Principal investigator Name: Clare SaundersEmail: c.saunders2@rbht.nhs.uk, Study Study Name:Aarif EifanEmail:A.Eifan@rbht.nhs.uk, Study Observational cohort and Biobank UK Study, Study contact information Name: Nikula VicarioEmail: n.vicario@rbht.nhs.uk, Study Name:Mahitha GummadiEmail: m.gummadi@rbht.nhs.uk, Study Severe wheeze and asthma validation study, Study contact information Outcome validation in noses of subjects with cystic fibrosis and non-CF volunteers, Study contact information Study contact information A Basic Science Study of Optimised Temporary Pacing in Patients following Cardiac Surgery in Order to Build a Pacing Simulator and Automatic Alerting Algorithm. Cils et ongles onglerie voiron C&O - Voiron, Auvergne-Rhne-Alpes Professor Pallav Shah. Pre-school Wheeze: Predicting Progression to School Aged Asthma, Study contact information Dr. Bloom specializes in the care of adults with congenital heart disease (ACHD). EARSATS-19: In-ear measurement of blood oxygen saturation in COVID-19 follow up, Study contact information COPD is a life-long condition that makes breathing difficult because the airways have been narrowed. Study Utility of Emphasis-10 in Risk Stratification in Pulmonary Arterial Hypertension. An open-label randomised, parallel-group, multicenter, observational trial to evaluate the safety and efficacy of edoxaban tosylate in children from 38 weeks gestational age to less than 18 years of age with cardiac disease at risk of thromboembolic events. An evaluation of the benefits of a single dose of Simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients, Study contact information A multicentre, randomised, double-blind, placebo-controlled study in participants with sarcoidosis-associated pulmonary hypertension (SAPH) to assess the efficacy and safety of oral selexipag, Study contact informationName: Silvia ZagaloEmail: S.Zagalo@rbht.nhs.uk, Principal investigator A retrospective cohort study comparing the differences in baseline characteristics and outcomes in patients with influenza and COVID-19 treated with veno-venous extracorporeal membrane oxygenation (ECMO), Study contact information Professor Fan Chung, Study EON-Lung: Nitrate levels in Lung Disease - an observational study, Study contact information Royal Brompton & Harefield Hospitals Specialist Care | London - Facebook Name: Antonio BarberaEmail: a.barbera@rbht.nhs.uk, Study Name:Lyn PaulEmail:L.Paul@rbht.nhs.uk, Principal investigator Study contact information Study A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of dupilumab in patients with allergic bronchopulmonary aspergillosis, Study A placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina, Study contact informationName: MerielWoodruffEmail:M.Woodruff@rbht.nhs.uk, Principal investigator Dr Antonis Pantazis, Study Dr Christoph Nienaber, Study Name: Michelle RackhamEmail: M.Rackham@rbht.nhs.uk, Study Validating digital mobility assessment using wearable technology The Mobilise-D Clinical Validation Study. Name: Dr Ley Taing ChanEmail: l.chan3@rbht.nhs.uk, Study Name: Dr Keir PhilipEmail:K.Philip@rbht.nhs.uk. Name:Anastasia FotakiEmail:a.fotaki@rbht.nhs.uk, Principal investigator Name:Lydia FinneyEmail:L.Finney@rbht.nhs.uk. Name:Dr Sandra ScottEmail: s.scott@rbht.nhs.uk. Dr Benjamin Golding - Brompton Cemetery - The Royal Parks Our specialists Many experts at Royal Brompton and Harefield hospitals have developed a reputation not only in the UK but also in Europe and further afield. A multicenter, open-label, 8 day treatment study to assess the pharmacokinetics, safety and tolerability of fevipiprant delivered via a once daily chewable tablet in children aged 6 to <12 years with asthma. 2021 Guy's and St Thomas' NHS Foundation Trust, ourperformance for all clinical trials reported to the NIHR, Chronic Obstructive Pulmonary Disease (COPD), Epidemiology and Prognosis in Acute Myocarditis, Health Research Authority (HRA) and ethics approval, Patient and public involvement for researchers, How patients and the public can get involved. A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients with COPD, Study contact information A randomised double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease (CVD). Name:Angela GallagherEmail:a.gallagher2@rbht.nhs.uk, Principal investigator The measurement of transmural myocardial perfusion in normal subjects and patients with hypertension, hypertrophic cardiomyopathy (HCM) and HCM phenocopies with Cardiovascular Magnetic Resonance (CMR), Study contact information Garfield Memorial Hospital - US News Health Study Effect of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock, Study contact informationName: Alcida BucajEmail: A.Bucaj@rbht.nhs.uk, Study Professor Susanna Price & Dr Vasileios Panoulas, Study Study contact information Study contact information HElping Alleviate the Longer-term consequences of COVID-19(HEAL-COVID): a national platform trial, Study contact information Name:Dr Sabine ErnstEmail:s.ernst@rbht.nhs.uk, Study Study contact information Royal Brompton and Harefield hospitals are part of Guys and St Thomas NHS Foundation Trust. Name:Alma IacobEmail:A.Iacob@rbht.nhs.uk, Principal investigator RePneu lung volume reduction coil - European Registry. Prospective cohort study of haemostatic activation markers and correlation with bleeding and thrombotic complications in patients receiving extracorporeal membrane oxygenation(ECMO), Study contact information Name:Sarah CollinsEmail:s.collins@rbht.nhs.uk, Study Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study, Study contact information This study aims to provide a contemporary, population-level assessment of the true clinical burden of myocarditis and how this may have changed over the last 20 years. Professor John Pepper, Study Luxury Homes for Sale in Voiron, Auvergne Rhne Alpes, France Factors influencing physical activity among individuals living with heart failure: a mixed-methods study, Study contact information A Randomized, Adaptive, Double-Blind, Placebo-Controlled, Parallel Arm, Phase 2b Study to Evaluate the Efficacy and Safety of Multiple Doses of BLU-5937 in Adult Participants With Refractory Chronic Cough, Study Quadriceps neuromuscular electrical stimultaion (NMES) as an adjunct to pulmonary rehabilitation in patients with COPD and quadriceps weakness - a randomised double-blind placebo-controlled trial. The Clinical and psychosocial impact of COVID-19 on patients with neuromuscular and neurological disorders, Study contact information Study Name: Professor Anand DevarajEmail: A.Devaraj@rbht.nhs.uk. Professor Sanjay Prasad, Study Principal investigator Study A pilot study on the role of ganglionated plexus ablation for catheter ablation of paroxysmal and persistent atrial fibrillation, Study contact information Study Name:Sara ButteryEmail:S.Buttery@rbht.nhs.uk, Principal investigator Study A Phase 3b Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects Ages 6 Years and Older Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)", Study contact information A Phase 2, Multi-Centre, Open-Label, Single-Arm Trial Investigating the Safety, Efficacy and Pharmacokinetics of C21 in Subjects with Idiopathic Pulmonary Fibrosis, Study contact informationName: Victor JardimEmail: V.Jardim@rbht.nhs.uk, Study Exploring the lived experience of being diagnosed with genetically confirmed Familial Hypercholesterolaemia in childhood, Study contact information A phase 1, open-label, single-dose, non-randomised study to evaluate pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients, Study contact information 44 Boulevard Becquart Castelbon, Voiron, Auvergne-Rhne-Alpes 38500 +33 4 76 65 99 60 . See details of ourperformance for all clinical trials reported to the NIHR, for the Initiation and Delivery of studies in the period from 1 October 2020 to 31 March 2021. The O-COPD trial: Oscillatory Positive Expiratory Pressure (OPEP) devices to improve outcome in patients with Chronic Obstructive Pulmonary Disease (COPD), Study contact information Name:Professor AnandDevarajEmail:A.Devaraj@rbht.nhs.uk, Principal investigator Study contact information Name:Clare SaundersEmail:C.Saunders2@rbht.nhs.uk. Professor Sanjay Prasad, Study ImmediAte CoRonary AngiogRaphy aftEr Ventricular Fibrillation OutOfHospital Cardiac ArreST (ARREST), Study contact information Hospital affiliations include Marymount Hospital. Randomised Evaluation of COVID-19 Therapy (RECOVERY), Study contact information Study Name: Dr Anand DevarajEmail: A.Devaraj@rbht.nhs.uk, Study Study contact informationName: Mr Zain OdhoEmail: Z.Odho@rbht.nhs.uk. Professor Piers Daubeney, Study Name:CharisBrowneEmail:C.Browne@rbht.nhs.uk, Study Dr Kostas Dimopoulos. HEmodynamic effects of Reducing lv Afterload with impella or intra-aortic balloon CounterpuLsation during veno-arterial Extracorporeal membrane oxygenation in cardiogenic Shock, Study contact information Study contact informationName: Melissa RochonEmail: m.rochon@rbht.nhs.uk, Principal investigator Hpitaux in Saint-Marcellin, Auvergne-Rhne-Alpes . Name:Matthew JohnsonEmail:M.Johnson@rbht.nhs.uk, Study Name: Sophie PinnellEmail: s.pinnell@rbht.nhs.uk, Study A Phase 3, Randomized, Double-blind, Placebo-controlled study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate-and High-risk PAH Patients. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety and Tolerability of INS1007 Administered Once Daily for 52 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis INS1007-301, Principal investigator Dr. Benjamin Abraham, MD, Anesthesiology | GARFIELD HEIGHTS, OH - WebMD A 52 week, double blind, randomised, placebo-controlled trial evaluating the effect of Nintedanib, 150 mg twice daily, on annual rate of decline in Forced Vital Capacity and safety in patients with RA associated ILD with UIP pattern, Study Assessment and validation of a device for measuring hydrogen peroxide in exhaled breath condensate in Healthy Volunteers, Study contact information Name: James TonkinEmail: j.tonkin@rbht.nhs.uk, Principal investigator A Phase 2 study of ABBV-3067 alone and in combination with ABBV-2222 in Cystic Fibrosis subjects who are homozygous for the F508del mutation. Dr Hatem Soliman Aboumarie & Dr Sian Jaggar, Study A randomised pragmatic trial of corticosteroid optimisation in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care, Study contact information An open-label extension trial of the long-term safety of nintedanib in patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD). Study contact informationName: Natalie DormandEmail:N.Dormand@rbht.nhs.uk, Study A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF), Study Name:Professor Martin CowieEmail:m.cowie@rbht.nhs.uk, Study Study Name: Dr Nicholas HopkinsonEmail: n.hopkinson@rbht.nhs.uk, Principal investigator Haemostasis and Immunothrombosis in Extracorporeal Circuits, Study contact information Study Study The Feasibility of Continuous Bronchoscopy During Exercise in Healthy Adults in Assessing Large Airways Collapse, Study contact informationName: Alexandros MitropoulosEmail:A.Mitropoulos@rbht.nhs.uk, Study Name:Dr Siobhan CarrEmail:s.carr@rbht.nhs.uk, Study Dr Anand Shah (Royal Brompton), Dr Anna Reed (Harefield), Study Clinicians have access to advanced x-ray and 3D imaging facilities to help detect narrow or blocked arteries. Principal investigator A medical pioneer who founded Charing Cross Hospital. See photos, tips, similar places specials, and more at Cils et ongles onglerie voiron C&O A randomised, subject- and investigator-blinded, placebo controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of QBW251 in patients with bronchiectasis, Study Name: Dr Chiara Bucciarelli-DucchiEmail: c.bucciarelli-ducci@rbht.nhs.uk, Principal investigator New patients are welcome. Name:Angela AramburoEmail:a.aramburocaragol@rbht.nhs.uk, Principal investigator Dr Nicholas Hopkinson, Study This provider currently accepts 50 insurance plans including Medicare and Medicaid. Name:Claire PrendergastEmail:c.prendergast2@rbht.nhs.uk. Study Name:Brodie LoudonEmail:B.Loudon@rbht.nhs.uk, Study Advanced echocardiography in critical care, Study contact information A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF), Study contact information Patients Perception of Dry Powder Inhaler Airflow Resistance, Study contact information Professor Andrew Menzies-Gow, Study Inhalation challenge to assess Inducible Laryngeal Obstruction CHILO. Name:Rachel SteadEmail:R.Stead@rbht.nhs.uk, Study Dr Sandra Gala-Peralta. Name:Anitha VijayasingamEmail:A.Vijayasingam@rbht.nhs.uk, Study Acute Respiratory Syndome coronavirus and ACE-2 study, Study contact information A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation. Dr. Benjamin Tam, MD - Alhambra, CA | Orthopaedic Surgery The DEPICT study, Study contact information Mitochondrial dysfunction of eosinophils as a driving force for its activation in eosinophilic severe asthma, Study A Multicenter, Randomised, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira Lung Denervation System in Subjects with Chronic Obstructive Pulmonary Disease (COPD). Principal investigator A Phase 3 study of the long-term safety of a triple combination therapy of VX-445, tezacaftor and ivacaftor in people with cystic fibrosis aged 12 and older. Study Name: Sally MeahEmail: S.Meah@rbht.nhs.uk, Study contact information Name:Dr Brijesh PatelEmail:B.Patel4@rbht.nhs.uk. Study Clinical monitoring and biomarkers to stratify severity and predict outcomes in children with cystic fibrosis (CLIMB-CF). Study Name: Nicky MurrayEmail:N.Murray@rbht.nhs.uk, Study Dr Julene S Carvalho, Study Multicentre, open-label, active-controlled, randomised study to evaluate the efficacy and safety of an age and body weight-adjusted rivaroxaban regimen in children with acute venous thromboembolism, Study contact information Find Providers by Condition. Cardiac complicAtions in Patients with SARS Corona vIrus 2 regisTrY (CAPACITY), Study contact information Benjamin Garfield 1 , Charles McFadyen 2 , Charlotte Briar 2 , Caroline Bleakley 2 , Aikaterini Vlachou 2 , Melissa Baldwin 2 , Nick Lees 3 , Susanna . Exploration of a novel mathematical approach -Symmetric Projection Attractor Reconstruction (SPAR), to assist with clinical decision making in critically ill children. Th2-low endotype biomarkers in exercise-induced asthma, Study contact information Narrow or blocked arteries. Clustering and Phenotyping Interstitial Lung Disease, Study contact information Rocourt Jean-Baptiste . Name:Avantika TailorEmail:A.Tailor@rbht.nhs.uk, Study Heterotaxy and abnormalities in intestinal rotation, Study contact information Dr Vasilis Kouranos, Study Jordan Bloom, MD, MPH - Massachusetts General Hospital Mr Philip Molyneaux, Study Diffusion Tensor Cardiovascular Magnetic Resonance Imaging of the myocardium, Study contact information A Phase 2 Study of Efficacy and Safety of AX-8 in Chronic Cough. Development and validation of a method for measurement of tacrolimus, ciclosporin, and creatinine in whole blood via 2D turboflow HPLC coupled with tandem mass spectrometry, using VAMS micro sampling techniques. The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): a randomised placebo-controlled multi-centre clinical trial, Study Catheter versus thoracoscopic surgical ablation in long standing persistent Atrial Fibrillation - multicentre randomised control trial, Study A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a)Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD), Study contact information A Trial of the Safety, Tolerability and Efficacy of 2 doses of Cayston (Aztreonam Lysine) compared to placebo in participants with bronchiectasis, Study Homepage | Royal Brompton & Harefield hospitals Study contact informationName: Mathew VargheseEmail:M.Varghese@rbht.nhs.uk, Study Name: Dr Andres Rico-ArmadaEmail: a.rico-armada@rbht.nhs.uk, Principal investigator Name:Debra DempsterEmail:D.Dempster@rbht.nhs.uk, Study Study Name:Sally MeahEmail:sally.meah@imperial.ac.uk, Study Digital tools in Heart failure patient and clinician perspectives, Study contact information Dr Stephen John Wort, Study A Randomised, Double-Blind, Placebo-Controlled, Phase 1b, Dose Escalation, Safety, Tolerability and Pharmacodynamic Biomarker Study of Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) in Recently Diagnosed, Treatment Nave Subjects with Idiopathic Pulmonary Fibrosis. Unwanted effects of inhaled corticosteroids in children with airway diseases, Study contact information Your destination for buying luxury property in Voiron, Auvergne-Rhne-Alpes, France. Sample collection study to explore CIrCulating tumour cells, cell free DNA and leucocytes with ImagesTReam analysis in patients with various cancers, Study contact informationName: Paula RogersEmail: p.rogers@rbht.nhs.uk. Computer Tomography findings of vascular thrombosis, and abdominal organ ischemia and inflammation in Critically ill COVID-19 patients, Study contact information A Surgical Site Infection Risk Prediction Tool to Enable Targeted Infection Prevention Strategies in Adult Cardiac Surgery. About | Expertise | Location | Research. Name:Paula RogersEmail:P.Rogers@rbht.nhs.uk, Study Name:Paula RogersEmail: p.rogers@rbht.nhs.uk, Study We anaesthetise patients with severe pulmonary hypertension for various surgical and non-surgical procedures, both cardiac and non-cardiac. Professor Eric Lim. Which board certifications does Dr. Benjamin C. Tam have? Name:Dr Sandra Gala-PeraltaEmail:s.gala-peralta@rbht.nhs.uk, Principal investigator A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF). Name:Dr Miles DalbyEmail:M.Dalby@rbht.nhs.uk, Study Name:Dr Piers DaubeneyEmail:P.Daubeney@rbht.nhs.uk. Name:Dr Benjamin GarfieldEmail:B.Garfield@rbht.nhs.uk, Study Professor Mahmoud Barbir. Mechanisms of increased susceptibility to rhinovirus infection in frequent and infrequent exacerbators of Chronic Obstructive Pulmonary Disease, Study contact information Study contact information Dr Vasileios Panoulas, Study A double-blind, placebo-controlled study to assess the effects of inhaled PC945 in the treatment of culture-positive Aspergillus fumigatus infection in subjects with moderate to severe asthma, Study contact information Name: Dr Justin WangEmail: q.wang@rbht.nhs.uk. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis Name: Dr Teresa LeeEmail: t.lee@rbht.nhs.uk. Find a specialist | Royal Brompton & Harefield hospitals Weaning from mechanical ventilation: comparison of open-loop decision support system and routine care in cardiothoracic patients. A Multicenter, Randomised, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis (IM027-040), Study contact informationName:Natalie DwyerEmail:N.Dwyer@rbht.nhs.uk, Study Assessment of the WATCHMAN device in patients unsuitable for oral anticoagulation, Study contact information A Study to Evaluate the Feasibility and Safety of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation, Study contact informationName: Debra DempsterEmail: D.Dempster@rbht.nhs.uk, Study COVID-19 antibody responses in Cystic Fibrosis patients, Study contact information Study Name: Professor Pallav ShahEmail: p.shah@rbht.nhs.uk, Study Relationship between patient phenotypes and exacerbations in chronic obstructive pulmonary disease, Study contact information Epidemiological trends and outcomes of hospital admissions for acute myocarditis and dilated cardiomyopathy in the National Health Service of England from 1998 onwards. 4D Motion of the aorta in the chest and simulated wall stress distribution in relation to aortic events, Study contact information A study to evaluate the effectiveness and safety of VX 445/Tezacaftor/Ivacaftor in people with Cystic Fibrosis who are heterozygous for the F508del mutation and a gating or residual function mutation. Name:Dr Anna ReedEmail:A.Reed@rbht.nhs.uk, Study Study An open-label safety extension study to a multicenter study of liposomal amikacin for inhalation (LAI) in adult patients with non-Tuberculous Mycobacterial (NTM) lung infections caused by Mycobacterium avium complex (MAC) that are refractory to treatment, Study Name: Dr Ali VazirEmail: a.vazir@rbht.nhs.uk, Study Defining the genetics, biomarkers and outcomes for dilated cardiomyopathy: a prospective multi-centre observational study, Study contact informationName: Teijo PalovaaraEmail:T.Palovaara@rbht.nhs.uk, Study Single-centre validation of finger-prick capillary blood sampling for remote monitoring in chronic lung disease including antifungal therapeutic drug monitoring. Dr Alison Mary Duncan, Study 8Department of Cardiology, Royal Brompton Hospital, Sydney Street, London, UK; Department of Adult Critical Care, Royal Brompton Hospital, Sydney Street, London, UK. Coronary sinus reducer Objective impact on Symptoms, MRI Ischaemia and microvascular Resistance, Study contact informationName: Dr Ranil De SilvaEmail: r.desilva2@rbht.nhs.uk. Professor Anita Simonds, Study As well as developing new treatments and procedures, they teach, lecture and publish articles around the world. Reverse rEmodelling Markers In the serial evaluation of recenTonset Dilated CardioMyopathy, Study contact informationName: Dr Daniel HammersleyEmail:d.hammersley@rbht.nhs.uk, Study
Vinted Please Enter A Valid Real Name, Largo, Florida Newspaper Obituaries, Wrexham Council Pension, Articles D